-
Part 2 | Session 4 Session 2.3: Imaging Focus
-
Part 2 | Session 5 Session 2.4: Live Cases & Discussions
-
Part 2 | Session 6 Day Two Close
-
Part 3 | Session 1 Day Welcome: Debates & Controversies
-
Part 3 | Session 2 Session 3.1: Keynote & Debates
-
Part 3 | Session 3 Session 3.2: Live Cases & Discussions
-
Part 3 | Session 4 Session 3.3: Controversies
-
Part 3 | Session 5 Day Three Close
-
Part 1 | Session 1 Day Welcome: Structural Heart Disease
-
Part 1 | Session 3 Session 1.2 Live Cases & Discussions
-
Part 1 | Session 4 Session 1.3: Revalving for Transcatheter Heart Valve Failure
-
Part 1 | Session 5 Session 1.4: Live Cases & Discussions
-
Part 1 | Session 6 Day One Close
-
Part 2 | Session 1 Day Welcome: Complex PCI
-
Part 2 | Session 2 Session 2.1: Coronary Calcifications Updates
TIO 2024 brought together an outstanding international faculty, creating an unparalleled interactive experience that will keep the global interventional cardiology community up-to-date with the latest advancements in transcatheter treatment strategies. Featuring a combination of expert opinions, engaging discussions, insightful presentations and live cases from prominent medical centres on both sides of the Atlantic, TIO delivered the highest-quality CME-accredited education.
Related Content:
Key Learning Objectives
- Review planning and valve selection strategies in patients with prior valve failure
- Summarise recent repair and replacement data in mitral and tricuspid regurgitation
- Select suitable tools for undertaking PCI in calcified lesions
- Optimise use of imaging in daily practice
- Outline the pros and cons of using P2Y12 inhibitors universally following PCI
- Identify situations where an IVUS or OCT-guided approach are preferable
- Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates & Controversies
Faculty Biographies
Ajay J Kirtane
Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.
In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…
Margaret B McEntegart
Director of Complex PCI and CTO Programmes
Dr Margaret McEntegart serves as the Director of Complex PCI and CTO programmes at Columbia University Irving Medical Center, New York, US. She also holds the role of Director of Cardiac Catheterization Laboratories at Columbia University Irving Medical Center / New York-Presbyterian Hospital.
Before joining Columbia, Dr McEntegart served as a consultant interventional cardiologist at Golden Jubilee National Hospital (UK), where she played a pivotal role in establishing and leading the CTO and Complex PCI Programme.
Azeem Latib
Section Head of Interventional Cardiology
Dr Mohamed Azeem Latib was born and raised in South Africa, where he also completed his early medical training. He later advanced his clinical and professional career internationally. He now resides in New York City, where he serves as the Section Head and Director of Interventional Cardiology and the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart & Vascular Care. His career has spanned multiple countries and premier cardiovascular institutions.
Academic History
Dr Latib earned his Bachelor of Medicine, Bachelor of Surgery (MB BCh) from the University of the Witwatersrand in Johannesburg, South Africa, in 1995. He completed a fellowship with the College of Physicians of South Africa in 2002 and received his certificate in cardiology in 2005.
He pursued advanced subspecialty training in Europe, completing a Master’s degree in Interventional Cardiology at the San Raffaele Scientific Institute and University…
Giuseppe Tarantini
Prof Giuseppe Tarantini is the Head of the Interventional Cardiology Unit within the Department of Cardiac, Thoracic, and Vascular Sciences at the University of Padua Medical School, Padua, IT. He is a globally recognised researcher specialising in ischemic heart disease, structural heart disease, and cardiomyopathies.
Prof Tarantini serves as the primary operator for a diverse array of interventional procedures, encompassing coronary interventions (including atherectomies), peripheral interventions (such as carotid and renal procedures), and structural heart interventions (involving ASDs, PFOs, TAVI, and AVP).
In addition to his clinical work, Prof Tarantini is a distinguished faculty member at various international conferences, including Transcatheter Cardiovascular Therapeutics (TCT), the Congresso della Societa Italiana di Cardiologia Invasiva (SICI-GISE), Euro PCR, and the European Society of Cardiology (ESC). He boasts a publication record of 245 clinical…
Comments